Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab. Kennedy NA, Goodhand JR, Bewshea C, Nice R, et al. Gut 2021;70:865-875.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kennedy NA, Goodhand JR, Bewshea C, Nice R, et al. Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab. Gut 2021;70:865-875.
PMID: 33753421